Product News: Rapid Antibody and Protein Production using the MaxCyte® STX™ Transfection System

09 Sep 2011

The MaxCyte STX Scalable Transfection System provides an ideal solution for rapidly expressing a large number of antibodies or proteins in the required quantities for use in screening and other preclinical drug development applications. The MaxCyte STX uses flow electroporation to reproducibly transfect an array of cell types, including CHO, HEK, insect cells, and other cell types commonly used for protein production.

The MaxCyte STX is a fully scalable instrument. It can transfect from 5x105 cells in seconds, up to 1x1010 cells in less than 30 minutes using pre-loaded electroporation protocols optimized for maximum protein production. The MaxCyte STX presents a practical solution to the time, labor and cost challenges faced when relying exclusively on stable cell lines for antibody or protein production. This system can produce proteins faster and at a lower cost than stable cell lines allowing users to more effectively focus their limited resources.

To learn more about the bioprocessing and antibody production capabilities of the MaxCyte STX, visit the stands at several upcoming conferences, where questions can be answered and product demonstrations can be seen.

Conferences include:

10th Conference on Protein Expression in Animal Cells (PEACe)
September 25-29, 2011
Cascais, Portugal

PEGS Europe
October 11-13, 2011
Hannover, Germany

Antibody Engineering & Therapeutics
December 5-8, 2011
San Diego, CA

To download some recent resources and find out more information about MaxCyte STX Scalable Transfection System capabilities visit the link to the company article page on the right.